Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Louisiana Business Tribune.
Press releases published on May 8, 2025
Inseego Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Q1 2025 revenue of $31.7 million Q1 2025 positive Adjusted EBITDA of $3.7 million and GAAP Net Loss of $1.6 million Ninth consecutive quarter of positive Adjusted EBITDA SAN DIEGO, May 08, 2025 (GLOBE NEWSWIRE) -- Inseego Corp. (Nasdaq: INSG) (the “Company …
Brilliant Earth Announces Participation in B. Riley Securities 25th Annual Investor Conference
GlobeNewswire
·
May 8, 2025
SAN FRANCISCO, May 08, 2025 (GLOBE NEWSWIRE) -- Brilliant Earth Group, Inc. (“Brilliant Earth” or the “Company”) (NASDAQ: BRLT), an innovative, global leader in ethically sourced fine jewelry, today announced that the Company will participate in the B. …
Aqua Metals Expands Product Platform with Advancements in Nickel, MHP, and LFP Recycling; Reports First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
RENO, Nev., May 08, 2025 (GLOBE NEWSWIRE) -- Aqua Metals (NASDAQ: AQMS), an innovator in domestic critical minerals refining, AquaRefining™, today reported financial results for the first quarter ended March 31, 2025, and highlighted major technology and …
Profound Medical Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
TORONTO, May 08, 2025 (GLOBE NEWSWIRE) -- Profound Medical Corp. (NASDAQ:PROF; TSX:PRN) (“Profound” or the “Company”), a commercial-stage medical device company that develops and markets customizable, AI-powered, incision-free therapies for the ablation of …
MARA Announces First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
Revenues increased 30% YoY to $214 million Bitcoin holdings increased 174% YoY to 47,531 from 17,320 at the end of Q1 2024 Fort Lauderdale, FL, May 08, 2025 (GLOBE NEWSWIRE) -- MARA Holdings, Inc. (NASDAQ: MARA) ("MARA" or the "Company"), a vertically …
Oportun Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
GAAP Net income of $9.8 million increased $36 million year-over-year GAAP EPS of $0.21 increased $0.89 year-over-year Adjusted EPS of $0.40 increased $0.31 year-over-year Operating expenses of $93 million reduced 15% year-over-year Reiterating full year …
Soleno Therapeutics Announces Oral Presentations Featuring VYKAT(TM) XR in Prader-Willi Syndrome at ESPE and ESE 2025
GlobeNewswire
·
May 8, 2025
REDWOOD CITY, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- Soleno Therapeutics, Inc. (Soleno) (NASDAQ: SLNO), a biopharmaceutical company developing novel therapeutics for the treatment of rare diseases, today announced that it will present data from its …
ICU Medical Announces First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
SAN CLEMENTE, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- ICU Medical, Inc. (Nasdaq:ICUI), a leader in the development, manufacture and sale of innovative medical products, today announced financial results for the quarterly period ended March 31, 2025. First …
FAT BRANDS INC. REPORTS FIRST QUARTER 2025 FINANCIAL RESULTS
GlobeNewswire
·
May 8, 2025
Conference call and webcast today at 5:30 p.m. ET LOS ANGELES, May 08, 2025 (GLOBE NEWSWIRE) -- FAT (Fresh. Authentic. Tasty.) Brands Inc. (NASDAQ: FAT) (“FAT Brands” or the “Company”) today reported financial results for the fiscal first quarter ended …
Pliant Therapeutics Provides Corporate Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Activities supporting the close out of BEACON-IPF continue; topline data expected in the second quarter of 2025 Recently announced strategic realignment of workforce and operations will extend cash runway to support execution of late-stage clinical trials …
La Croix-Rouge canadienne insiste sur la nécessité de protéger le personnel humanitaire après un nombre record de décès en 2024
GlobeNewswire
·
May 8, 2025
OTTAWA, Ontario, 08 mai 2025 (GLOBE NEWSWIRE) -- À l’occasion de la Journée de la Croix-Rouge et du Croissant-Rouge, la Croix-Rouge canadienne appelle à la protection du personnel humanitaire dans le monde entier. Déjà, cette année, le Mouvement …
Texas Roadhouse, Inc. Announces First Quarter 2025 Results
GlobeNewswire
·
May 8, 2025
LOUISVILLE, KY., May 08, 2025 (GLOBE NEWSWIRE) -- Texas Roadhouse, Inc. (NasdaqGS: TXRH), today announced financial results for the 13 weeks ended April 1, 2025. Financial Results Financial results for the 13 weeks ended April 1, 2025 and March 26, 2024 …
Nanox to Report First Quarter 2025 Financial Results on May 22, 2025
GlobeNewswire
·
May 8, 2025
PETACH TIKVA, Israel, May 08, 2025 (GLOBE NEWSWIRE) -- NANO-X IMAGING LTD ("Nanox" or the "Company", Nasdaq: NNOX), an innovative medical imaging technology company, today announced that it will report its financial results for the quarter ended March 31, …
AVITA Medical Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
VALENCIA, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- AVITA Medical, Inc. (NASDAQ: RCEL, ASX: AVH), a leading therapeutic acute wound care company delivering transformative solutions, today reported financial results for the first quarter ended March 31, 2025 …
PDF Solutions® Announces First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
SANTA CLARA, Calif., May 08, 2025 (GLOBE NEWSWIRE) -- PDF Solutions, Inc. (Nasdaq: PDFS), a leading provider of comprehensive data solutions for the semiconductor and electronics ecosystem, today announced financial results for its first quarter ended …
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2025 Financial Results
GlobeNewswire
·
May 8, 2025
Soquelitinib data from cohorts 1-3 of atopic dermatitis Phase 1 clinical trial demonstrate favorable safety and efficacy profile, including earlier and deeper responses in cohort 3 compared to cohorts 1-2 Phase 3 registrational clinical trial of …
Metsera to Present at Bank of America 2025 Global Healthcare Conference
GlobeNewswire
·
May 8, 2025
NEW YORK, May 08, 2025 (GLOBE NEWSWIRE) -- Metsera, Inc. (Nasdaq: MTSR) (“Metsera” or the “Company”), a clinical-stage biopharmaceutical company accelerating the next generation of medicines for obesity and metabolic diseases, today announced that Whit …
Iovance Biotherapeutics Reports Financial Results and Corporate Updates for First Quarter 2025
GlobeNewswire
·
May 8, 2025
1Q25 Total Product Revenue of $49.3M FY25 Total Product Revenue Guidance Revised to $250M-$300M FY25 Operating Expenses Reduced and 2H26 Cash Runway Guidance Maintained 2025 Regulatory Approvals for Amtagvi® Expected in the UK, EU, and Canada On Track to …
Collegium Reports First Quarter 2025 Financial Results and Highlights Recent Company Progress
GlobeNewswire
·
May 8, 2025
– Generated Q1’25 Quarterly Net Revenue of $177.8 Million, Up 23% Year-over-Year – – Grew Jornay PM® Prescriptions by 24% Year-over-Year and Reported Quarterly Net Revenue of $28.5 Million; Jornay PM Prescribers Reached an All-Time-High – – Completed …
Ventyx Biosciences Reports First Quarter 2025 Financial Results and Highlights Recent Corporate Progress
GlobeNewswire
·
May 8, 2025
Topline data from multiple Phase 2 studies expected throughout 2025 • Q2 readout from VTX3232 study in patients with early Parkinson’s disease • H2 readout from VTX2735 study in patients with recurrent pericarditis • H2 readout from VTX3232 study in …